Design Therapeutics, Inc.
DSGN
$3.50
-$0.02-0.57%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 229.67M | 245.48M | 254.07M | 261.02M | 270.69M |
| Total Receivables | 1.41M | 1.26M | 1.18M | 1.40M | 1.68M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.57M | 1.30M | 1.99M | 2.43M | 1.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 233.64M | 248.04M | 257.24M | 264.84M | 273.89M |
|
|
|||||
| Total Current Assets | 233.64M | 248.04M | 257.24M | 264.84M | 273.89M |
| Net Property, Plant & Equipment | 3.40M | 3.63M | 3.96M | 4.31M | 4.48M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 427.00K | 427.00K | 427.00K | 429.00K | 427.00K |
| Total Assets | 237.48M | 252.09M | 261.63M | 269.58M | 278.79M |
|
|
|||||
| Total Accounts Payable | 3.18M | 2.19M | 1.47M | 1.30M | 1.37M |
| Total Accrued Expenses | 4.24M | 5.48M | 5.18M | 4.34M | 4.99M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 821.00K | 800.00K | 778.00K | 757.00K | 736.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.24M | 8.46M | 7.43M | 6.39M | 7.09M |
|
|
|||||
| Total Current Liabilities | 8.24M | 8.46M | 7.43M | 6.39M | 7.09M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.32M | 1.53M | 1.74M | 1.95M | 2.14M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.56M | 10.00M | 9.18M | 8.34M | 9.24M |
|
|
|||||
| Common Stock & APIC | 472.40M | 468.84M | 465.10M | 461.98M | 458.46M |
| Retained Earnings | -244.93M | -227.21M | -213.56M | -200.52M | -188.73M |
| Treasury Stock & Other | 450.00K | 475.00K | 914.00K | -217.00K | -167.00K |
| Total Common Equity | 227.92M | 242.10M | 252.45M | 261.24M | 269.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 227.92M | 242.10M | 252.45M | 261.24M | 269.56M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 227.92M | 242.10M | 252.45M | 261.24M | 269.56M |
|
|
|||||